Flexion garners $33M in Series A

Woburn, MA-based Flexion Therapeutics has raised an impressive $33 million in its first round. Versant Ventures led the round, which included 5AM Ventures and Sofinnova Partners. Mike Clayman and Neil Bodick, who founded Lilly's proof-of-concept drug unit, are heading the venture. And the company says it has deals in the works with three pharma companies. Flexion release

Suggested Articles

A few years ago, one of our Fierce editors met a Big Pharma R&D chief for the first time. “You’re the ones with the scary name,” he joked.

Pfizer's eczema hopeful has been building its case to challenge Sanofi and Regeneron's Dupixent, but safety issues could stand in its way.

Cedrik Britten, M.D., becomes the biotech’s new chief medical officer to help run its adoptive cell therapy and TCR bispecifics platform.